(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TUMORAD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TUMORAD

ST13

US500000097828462

Class

5

Filing

97828462

Registration

7518971

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

10/01/2024

Trademark type

Word

Nice classes

5

Filing date

03/08/2023

Registration date

10/01/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/01/2024

Last transaction

10/01/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Lund, SE

Examiner

BHANOT, KAPIL

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Spago Nanomedical AB

Representatives

Sana Hakim K&L GATES LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents; x-ray contrast agents for medical purposes; radiological contrast substances for medical purposes; contrast media for use in medical imaging; anti-cancer preparationscompounds for treating cancer; pharmaceutical preparations and products for the treatment of cancer; drug delivery agents in the form of nano-sized carriers that facilitate the delivery of pharmaceutical preparationschemicals used in medicine and nanomedical applicationschemical reagents for medical purposes and chemical preparations for pharmaceutical or medical purposesfor treating cancer

Publications

History of USPTO decisions and trademark events.

14 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/01/2024

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

08/24/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/24/2024

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/07/2024

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

03/07/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/05/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/09/2024

PUBO

PUBLISHED FOR OPPOSITION

01/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/20/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/06/2023

DOCK

ASSIGNED TO EXAMINER

12/06/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/13/2023

NWAP

NEW APPLICATION ENTERED

03/11/2023

Continuous trademark protection

Get notified about every new filing that threatens TUMORAD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.